Fibrinolysis of intraventricular hematoma with tissue plasminogen activator;Fibrinolyse intraventrikularer hamatome mit rt-PA

Nervenarzt

Volumn 70, Issue 2, 1999, Pages 123-130

  Schwarz, S ^a   Schwab, S ^a   Steiner, H H ^b   Hanley, D ^c   Hacke, W ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Intracerebral hemorrhage; Intraventricular hemorrhage; Tissue plasminogen activator; Ventricular drainage

Indexed keywords

ALTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BLEEDING; BRAIN HEMATOMA; CLINICAL ARTICLE; DRUG EFFECT; DRUG SCREENING; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; AGED; BRAIN HEMORRHAGE; BRAIN VENTRICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; HEMATOMA; MIDDLE AGED; RADIOGRAPHY;

ADULT; AGED; CEREBRAL HEMORRHAGE; CEREBRAL VENTRICLES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMATOMA; HUMANS; INJECTIONS, INTRAVENTRICULAR; MALE; MIDDLE AGED; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033037535     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050412     Document Type: Article

References (28)

1. Akdemir H, Selcuklu A, Pasaoglu A, Oktem IS, Kavuncu I (1995) Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. Neurosurg Rev 18:95-100
2. Aydin IH, Takci E, Kadioglu HH, Kayaoglu CR, Tuzun Y (1994) The effect of urokinase on experimental intracerebral haematomas. Zentralbl Neurochir 55:29-34
3. Brott T, Broderick J, Kothari, Barsan W, Tomsick T, Sauerbeck L, Spilker J, Duldner J, Khoury J (1997) Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 28:1-5
4. Daverat P, Castel JP, Dartigues JF, Orgogozo JM (1991) Death and functional outcome after sponataneous intracerebral hemorrhage. Stroke 22:1-6
5. Findlay JM, Grace MGA, Weir BKA (1993) Treatment of intraventricular hemorrhage with tissue plasminogen activator. Neurosurgery 32:941-947
6. Findlay JM, Kassell NF, Weir BKA, Haley EC, Kongable G, Germanson T, Truskowski L, Alves WM, Holness RO, Knuckey NW, Yonas H, Steinberg K, West M, Winn R, Ferguson G (1995) A randomized trial of intraoperative, intracisternal plasminogen activator for the prevention of vasospasm. Neurosurgery 37:168-178
7. Findlay JM, Weir KA, Stollery DE (1991) Lysis of intraventricular hematoma with tissue plasminogen activator. J Neurosurg 74:803-807
8. Fujii Y, Tanaka R, Takeuchi S, Koike T, Minakawa T, Sasaki O (1994) Hematoma enlargement in spontaneous intracerebral hemorrhage. J Neurosurg 80:51-57
9. Hindersin P, Endler S (1984) Alterations of coagulation and fibrinolysis in cerebrospinal fluid. Basic concept of antifibrinolytic therapy of subarachnoid haemorrhage. Acta Neurochir Suppl (Wien) 34:1-77
10. Kajimoto Y, Ohta T, Kuroiwa T (1997) Comparison of intrathecally administered urokinase, tissue-type plasminogen activator, and combination of urokinase and lysine-plasminogen for clot lysis after experimental subarachnoid hemorrhage in dogs. Neurosurgery 40:572-577
11. Kinugasa K, Kamata I, Hirotsune N, Tokunaga K, Sugui K, Handa A, Nakashima H, Ohmoto T, Mandai S, Matsumoto Y (1995) Early treatment of subarachnoid hemorrhage after preventing rerupture of an aneurysm. J Neurosurg 83:34-41
12. Lee KS, Bae HG, Yun IG (1990) Recurrent intracerebral hemorrhage due to hypertension. Neurosurgery 26:586-590
13. Lisk DR, Pasteur W, Rhoades H, Putnam RD, Grotta JC (1994) Early presentation of hemispheric intracerebral hemorrhage: prediction of outcome and guidelines for treatment allocation. Neurology 44:133-139
14. Matsumoto K, Hondo H (1990) CT-guided stereotaxic evacuation of hypertensive intracerebral hemorrhage. J Neurosurg 61:440-448
15. Mayfrank L, Kissler J, Raoofi R, Delsing P, Weis J, Küker W, Gilsbach JM (1997) Ventricular dilatation in experimental intraventricular hemorrhage in pigs. Stroke 28:141-147
16. Mayfrank L, Lippitz B, Groth M, Bertalanffy H, Gilsbach JM (1993) Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage. Acta Neurochir 122:32-38
17. Mayhall CG, Archer NH, Lamb VA (1984) Ventriculostomy-related infections: a prospective epidemiological study. N Engl J Med 310:553-557
18. Pang D, Sclabassi RJ, Horton JA (1986) Lysis of intraventricular blood clot with urokinase in a canine model. Part 2. In vivo safety study of intraventricular urokinase. Neurosurgery 19:547-552
19. Pang D, Sclabassi RJ, Horton JA (1986) Lysis of intraventricular blood clot with urokinase in a canine model. Part 3. Effects of intraventricular urokinase on clot lysis and posthemorrhagic hydrocephalus. Neurosurgery 19:553-572
20. Rainov NG, Burkert WL (1995) Urokinase infusion for severe intraventricular haemorrhage. Acta Neurochir 134:55-59
21. Rohde V, Schaller C, Hassler WE (1995) Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular haemorrhage. J Neurol Neurosurg Psychiatry 58:447-451
22. Shapiro AS, Campbell RL, Scully T (1994) Hemorrhagic dilation of the forth ventricle: an ominous predictor. J Neurosurg 80:805-809
23. Shen PH, Matsuoka Y, Kawajiri K, Kanai M, Hoda K, Yamamoto S, Nishimura S (1990) Treatment of intraventricular hemorrhage using urokinase. Neurol Med Chir Tokyo 30:329-333
24. Stolke D, Seifert V (1992) Single intracisternal bolus of recombinant tissue plasminogen activator in patients with aneurysmal subarachnoid hemorrhage: preliminary assessment of efficacy and safety in an open clinical study. Neurosurgery 30:877-881
25. Todo T, Usui M, Takakura K (1991) Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. J Neurosurg 74:81-86
26. Usui M, Saito N, Hoya K, Todo T (1994) Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone. Neurosurgery 34:235-245
27. Whitelaw A, Saliba E, Fellman V, Mowinckel MC, Acolet D, Marlow N (1996) Phase I study of intraventricular recombinant tissue plasminogen activator for treatment of post haemorrhagic hydrocephalus. Arch Dis Child Fetal Neonatal Ed 75:F20-26
28. Zabramski JM, Spetzler RF, Lee KS, Papadopoulos SM, Bovill E, Zimmerman RS, Bederson JB (1991) Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 75:189-196